What is the reason for the Zantac recall?
What is the reason for the Zantac recall?
The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day).
What was Zantac causing?
Zantac and other ranitidine products contaminated with NDMA, a probable human carcinogen, may be linked to many types of cancer, including bladder cancer, colon cancer and prostate cancer.
Is Zantac ever coming back?
The bottom line. Due to a possible cancer risk, all forms of ranitidine were recalled by the FDA in 2020, including over-the-counter Zantac. This acid reflux medication has finally returned to pharmacy shelves but with a different ingredient called famotidine.
When did Zantac come out of the market?
Zantac (ranitidine) is one such drug. A popular OTC heartburn medication, Zantac was removed from store shelves in 2020 following a market withdrawal request from the U.S. Food and Drug Administration (FDA).
Why is Zantac being taken off the shelves?
Some stores are taking it a step further and taking all Zantac and generic ranitidine formulas off the shelves, regardless of the manufacturer. “The fact that it is over-the-counter means more people can potentially ingest dangerous chemicals,” Sonpal said.
What kind of drug is Zantac and what does it do?
Zantac (ranitidine) belongs to a group of drugs called histamine-2 blockers. Ranitidine works by reducing the amount of acid your stomach produces.
Are there any lawsuits against Zantac for cancer?
Attorneys and injured patients recently filed Zantac cancer lawsuits throughout the United States. In fact, Attorney Sibley Dolman is presently investigating several hundred claims of being diagnosed with cancer as a result of using Zantac.